"Successful results of the Phase II pilot trial should pave the way for the initiation of a pivotal Phase III by year-end. In addition, the Phase II results may be sufficient to receive a CE Mark in Europe by year-end with a European launch early next year."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.